You have 9 free searches left this month | for more free features.

City

Beijing (2)

Condition

Rheumatoid Arthritis (2)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Hangzhou Highlightll Pharmaceutical Co., Ltd (2)

Collaborator

Intervention

tll-018 (2)

tofacitinib (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

tll-018

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

Not yet recruiting

Rheumatoid Arthritis

TLL-018
Tofacitinib

Beijing, Beijing, China

Peking Union Medical College Hospital

Aug 25, 2023

Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

Recruiting

Rheumatoid Arthritis

TLL-018
Tofacitinib

Beijing, Beijing, China

Peking Union Medical College Hospital

Apr 7, 2022